(Q38425167)
Statements
A phase II randomized study evaluating the addition of iniparib to gemcitabine plus cisplatin as first-line therapy for metastatic non-small-cell lung cancer (English)
S Novello
B Besse
F Barlesi
G Zalcman
J von Pawel
M Reck
D Ferry
E Carcereny
I Garcia-Ribas
G Scagliotti